U. S. Department of Justice conditionally approves Bayer’s proposed acquisition of Monsanto

Operations of Bayer and Monsanto to be integrated as soon as divestments to BASF have been accomplished ...

U.S. FDA accepts larotrectinib New Drug Application and grants priority review

Annual Stockholders’ Meeting 2018

Bayer is making good progress strategically

Acquisition of Monsanto expected to be closed in the near future / 2017 sales and earnings at the prior-year level ...

Bayer launches online training in good agricultural practices

Free online course in English starts on May 28 2018. Registration open now ...

Bayer highlights latest oncology research at ASCO 2018

Clinical research to be presented from Bayer’s growing oncology portfolio, including radium-223 dichloride, sorafenib, regorafenib, copanlisib and other pipeline compounds ...

Disappointing verdict requires in-depth analysis

General Court of the European Union decides that neonicotinoid restrictions imposed by European Commission in 2013 were lawful / Bayer will assess the verdict’s consequences and potential legal options ...

Bayer receives approval for Eylea® in China

Eylea® gains approval in China for the treatment of visual impairment due to neovascular (wet) age-related macular degeneration ...

CVBD® World Forum: Communication is key to managing vector-borne diesease threats in veterinary practice

Communications tools are needed to help achieve more meaningful outcomes in vector-borne disease prevention ...

Bayer announces Executive Leadership Team for new Crop Science division

Liam Condon to lead newly combined organization ...